Home › Funds › Blue Owl Capital Holdings LP › MRKR

Blue Owl Capital Holdings LP position in MRKR

MARKER THERAPEUTICS INC · Health Care

Blue Owl Capital Holdings LP reported holding 554,250 shares of MRKR (MARKER THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$593K, representing 0.11% of its reported portfolio and ranking #37 among its reported holdings. Blue Owl Capital Holdings LP has disclosed MRKR holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)554.25K sh
Reported value held$593.05K
Portfolio Weight0.11%
First reportedQ4 2024
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Blue Owl Capital Holdings LP's MRKR position evolved

Blue Owl Capital Holdings LP first disclosed a stake in MRKR in Q4 2024 at 554,250 shares (US$1.7M). Across 8 filings, Blue Owl Capital Holdings LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 554,250 shares valued at US$593K.

Quarter by quarter

QuarterSharesValueChange
Q4 2024 554.25K $1.72M New
Q1 2025 554.25K $681.73K Hold
Q2 2025 554.25K $848.00K Hold
Q3 2025 554.25K $494.72K Hold
Q4 2025 554.25K $825.83K Hold
Q1 2026 554.25K $720.52K Hold
Q2 2026 554.25K $814.75K Hold
Q3 2026 554.25K $593.05K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MRKR and 13F data

MRKR (MARKER THERAPEUTICS INC) is a Health Care company. 23 other funds we track also report a position in MRKR — the largest reported positions include NEA Management Company, LLC (US$2.4M), Aisling Capital Management LP (US$348K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MRKR

All MRKR fund holders →

FAQ

How long has Blue Owl Capital Holdings LP held MRKR?

Blue Owl Capital Holdings LP has disclosed MRKR holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is Blue Owl Capital Holdings LP's current position in MRKR?

As of Q3 2026, Blue Owl Capital Holdings LP holds 554.25K shares of MRKR (MARKER THERAPEUTICS INC), valued at $593.05K, representing 0.11% of its reported portfolio and ranking #37.

Has Blue Owl Capital Holdings LP been buying or selling MRKR?

In the latest 13F filing (Q3 2026), Blue Owl Capital Holdings LP held unchanged its position in MRKR.

Which other funds hold MRKR?

Other major institutional holders of MRKR include NEA Management Company, LLC, Aisling Capital Management LP, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.